The outbreak of novel coronavirus 2019-nCoV ("Coronavirus") is an extraordinary challenge for many transactions involving Chinese companies. In this section, we analyse its impact on certain key aspects of mergers and acquisitions ("M&A") and joint venture ("JV") transactions, the remedies that may be available under the share purchase agreement ("SPA") and joint venture agreement ("JVC"), and what the parties could do to manage the relevant risks.
Please see full publication below for more information.